Peripheral artery disease clinical trials

Explore recruiting peripheral artery disease clinical trials.

Recruiting peripheral artery disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peripheral artery disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

J2A-MC-GZPR: A Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants with Peripheral Artery Disease: A Randomized, Double-Blind, Placebo Controlled Trial

Slovakia, Poland, France, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with inflammatory rheumatic diseases based on the use of carotid ultrasound.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

IMPACT OF INTRAVENOUS IRON TREATMENT OF PREOPERATIVE ANEMIA IN PATIENTS WITH LOWER EXTREMITY PERIPHERAL ARTERY DISEASE (IRONPAD)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

TRACK - Treatment of cardiovascular disease with low dose Rivaroxaban in Advanced CKD.

Germany, Belgium, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial- LEADER PAD

Italy, Belgium, Netherlands, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Peripheral artery disease trials by city

Peripheral artery disease in Toronto Peripheral artery disease in Vancouver Peripheral artery disease in Montreal Peripheral artery disease in Calgary Peripheral artery disease in Edmonton Peripheral artery disease in Ottawa Peripheral artery disease in Winnipeg Peripheral artery disease in Quebec City Peripheral artery disease in Hamilton Peripheral artery disease in Kitchener Peripheral artery disease in London Peripheral artery disease in Halifax Peripheral artery disease in New York Peripheral artery disease in Los Angeles Peripheral artery disease in Chicago Peripheral artery disease in Houston

Other conditions

High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease IgA nephropathy Polycystic kidney disease Migraine Alzheimer's disease Parkinson's disease Multiple sclerosis Epilepsy ALS